Caplin Point surges after USFDA completes inspection at its Sterile Injectable site

01 Nov 2016 Evaluate

Caplin Point Laboratories is currently trading at Rs. 415.00, up by 17.60 points or 4.43% from its previous closing of Rs. 397.40 on the BSE.

The scrip opened at Rs. 402.20 and has touched a high and low of Rs. 424.80 and Rs. 402.20 respectively. So far 49,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 424.80 on 01-Nov-2016 and a 52 week low of Rs. 167.05 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 424.80 and Rs. 343.10 respectively. The current market cap of the company is Rs. 3,148.92 crore.

The promoters holding in the company stood at 69.09%, while Institutions and Non-Institutions held 4.90% and 26.01% respectively.

The United State Food and Drug Administration (USFDA) has completed inspection at Caplin Point Laboratories’ Sterile Injectable site (CP-IV) at Gummidipoondi between October 21 - 28, 2016. There were only two observations.

The company believes these to be of minor in nature and the corrective and preventive actions for these observations will be presented to the USFDA within the next 15 days. The observations made were not related to data integrity.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.


Caplin Point Lab Share Price

1952.40 25.50 (1.32%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×